HCTI vs MTEX

For growth investors, Mannatech, Incorporated (MTEX) is the stronger pick with -10.

7% revenue growth year-over-year, versus -64. 8% for Healthcare Triangle, Inc. (HCTI). Mannatech, Incorporated (MTEX) offers the better valuation at 3. 5x trailing P/E, making it the more compelling value choice. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Mannatech, Incorporated (MTEX) delivered a total return of -61.

0%, compared to -100. 0% for Healthcare Triangle, Inc. (HCTI). Over 10 years, the gap is even starker: MTEX returned -35. 2% versus HCTI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Mannatech, Incorporated (MTEX) is the lower-risk stock at 0.

27β versus Healthcare Triangle, Inc. 's 3. 07β — meaning HCTI is approximately 1047% more volatile than MTEX relative to the S&P 500.

By revenue growth (latest reported year), Mannatech, Incorporated (MTEX) is pulling ahead at -10.

7% versus -64. 8% for Healthcare Triangle, Inc. (HCTI). On earnings-per-share growth, the picture is similar: Mannatech, Incorporated grew EPS 210. 0% year-over-year, compared to 45. 6% for Healthcare Triangle, Inc.. Over a 3-year CAGR, MTEX leads at -9. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Mannatech, Incorporated (MTEX) is the more profitable company, earning 2.

1% net margin versus -51. 0% for Healthcare Triangle, Inc. — meaning it keeps 2. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MTEX leads at 1. 2% versus -40. 6% for HCTI. At the gross margin level — before operating expenses — MTEX leads at 77. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Mannatech, Incorporated (MTEX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

27)). Healthcare Triangle, Inc. (HCTI) carries a higher beta of 3. 07 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MTEX: -35. 2%, HCTI: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (HCTI (Healthcare) and MTEX (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HCTI is a small-cap quality compounder stock; MTEX is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.